Factor XIa — Drug Target
All drugs that target Factor XIa — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (3)
- KHK4827 · Kyowa Kirin Co., Ltd. · Factor XIa inhibitor · Cardiovascular
KHK4827 is a Factor XIa inhibitor that reduces thrombin generation by blocking a key enzyme in the intrinsic coagulation pathway. - KHK7791 · Kyowa Kirin Co., Ltd. · Factor XIa inhibitor · Cardiovascular
KHK7791 is a Factor XIa inhibitor that reduces thrombin generation by blocking a key coagulation cascade enzyme, thereby reducing thrombotic risk. - KHK7580 · Kyowa Kirin Co., Ltd. · Factor XIa inhibitor · Cardiovascular
KHK7580 is a Factor XIa inhibitor that reduces thrombin generation by blocking a key enzyme in the intrinsic coagulation pathway.